ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Abeona Therapeutics (ABEO)
Abeona Therapeutics stock price today, ATLAS forecast and fair value
Healthcare · Biotechnology · NASDAQ
$4.47▲ +3.60%
Prices as of Oct 27, 2026 · USD
Chance of rising in 1 month
48%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Abeona Therapeutics in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Abeona Therapeutics
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Abeona Therapeutics a 48% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between $4.02 and $4.89; in 9 out of 10, between $3.38 and $5.82. Estimated annual volatility is 51%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- $288M
- 52-week high
- $7.65
- 52-week low
- $4.00
- Revenue (12 months)
- $25.5M
- Gross margin
- 41.2%
- Return on equity
- -43.1%
- Free cash flow (12 months)
- $-73.4M
- Beta
- 1.32
What this means
ATLAS does not publish a fair value for ABEO right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks ABEO has traded between $4.00 and $7.65. Today it is 41.6% below that high and 12% above its low.
Its beta is 1.32: it tends to move more than the market, both up and down.
About the company
Abeona Therapeutics Inc. is a commercial-stage biopharmaceutical company focused on developing and delivering cell and gene therapies for serious rare diseases.
Want to see everything about Abeona Therapeutics?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Abeona Therapeutics do?
Abeona Therapeutics Inc. is a commercial-stage biopharmaceutical company focused on developing and delivering cell and gene therapies for serious rare diseases.
What is the chance ABEO goes up next month?
48%: close to a coin flip. In half of the simulated outcomes, ABEO ends the month between $4.02 and $4.89.
How big is Abeona Therapeutics and what is its P/E ratio?
Abeona Therapeutics's market capitalization is $288M. We do not show a P/E because it has no positive earnings to base one on.
How volatile is ABEO?
ATLAS estimates annual volatility at 51%. In a typical month, half of the outcomes end between $4.02 and $4.89.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer